glp-1 news october 1 2025 obesity drug 21 Perspectives from employers on the costs and issues associated with covering agonists for weight loss Eli Lilly to seek approval – How Pharmacy Plans Are Managing

For those specifically interested in the science behind dosing strategies, the tool demonstrates how reconstitution and dose volumes are mathematically derived but it is not guidance for personal weight loss or medical application

Most users report noticeable changes in sleep quality, recovery, and performance within 24 weeks

For therapeutic applications during the In-Competition period, consider the use of alternative permitted medications in consultation with a physician, or apply for a Therapeutic Use Exemption for the use of pseudoephedrine for therapeutic reasons

In the next section, we will focus on the diverse roles of GLP-1 in depression ( Table 1 )